224 related articles for article (PubMed ID: 10877249)
1. Factors influencing pain outcome in herpes zoster: an observational study with valaciclovir. Valaciclovir International Zoster Assessment Group (VIZA).
Decroix J; Partsch H; Gonzalez R; Mobacken H; Goh CL; Walsh L; Shukla S; Naisbett B
J Eur Acad Dermatol Venereol; 2000 Jan; 14(1):23-33. PubMed ID: 10877249
[TBL] [Abstract][Full Text] [Related]
2. Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults.
Beutner KR; Friedman DJ; Forszpaniak C; Andersen PL; Wood MJ
Antimicrob Agents Chemother; 1995 Jul; 39(7):1546-53. PubMed ID: 7492102
[TBL] [Abstract][Full Text] [Related]
3. Open-label study of valacyclovir 1.5 g twice daily for the treatment of uncomplicated herpes zoster in immunocompetent patients 18 years of age or older.
Madkan VK; Arora A; Babb-Tarbox M; Aboutlabeti S; Tyring S
J Cutan Med Surg; 2007; 11(3):89-98. PubMed ID: 17511925
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the efficacy and safety of valaciclovir and acyclovir for the treatment of herpes zoster ophthalmicus.
Colin J; Prisant O; Cochener B; Lescale O; Rolland B; Hoang-Xuan T
Ophthalmology; 2000 Aug; 107(8):1507-11. PubMed ID: 10919899
[TBL] [Abstract][Full Text] [Related]
5. Valaciclovir: a review of its use in the management of herpes zoster.
Ormrod D; Goa K
Drugs; 2000 Jun; 59(6):1317-40. PubMed ID: 10882165
[TBL] [Abstract][Full Text] [Related]
6. Comparative study of the efficacy and safety of valaciclovir versus acyclovir in the treatment of herpes zoster.
Lin WR; Lin HH; Lee SS; Tsai HC; Huang CK; Wann SR; Chen YS; Chiang SC; Yen MY; Liu YC
J Microbiol Immunol Infect; 2001 Jun; 34(2):138-42. PubMed ID: 11456360
[TBL] [Abstract][Full Text] [Related]
7. Valaciclovir. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in herpesvirus infections.
Perry CM; Faulds D
Drugs; 1996 Nov; 52(5):754-72. PubMed ID: 9118821
[TBL] [Abstract][Full Text] [Related]
8. Treatment of acute herpes zoster: effect of early (< 48 h) versus late (48-72 h) therapy with acyclovir and valaciclovir on prolonged pain.
Wood MJ; Shukla S; Fiddian AP; Crooks RJ
J Infect Dis; 1998 Nov; 178 Suppl 1():S81-4. PubMed ID: 9852981
[TBL] [Abstract][Full Text] [Related]
9. Amenamevir, a novel helicase-primase inhibitor, for treatment of herpes zoster: A randomized, double-blind, valaciclovir-controlled phase 3 study.
Kawashima M; Nemoto O; Honda M; Watanabe D; Nakayama J; Imafuku S; Kato T; Katsuramaki T;
J Dermatol; 2017 Nov; 44(11):1219-1227. PubMed ID: 28681394
[TBL] [Abstract][Full Text] [Related]
10. Antiviral therapy for herpes zoster: randomized, controlled clinical trial of valacyclovir and famciclovir therapy in immunocompetent patients 50 years and older.
Tyring SK; Beutner KR; Tucker BA; Anderson WC; Crooks RJ
Arch Fam Med; 2000; 9(9):863-9. PubMed ID: 11031393
[TBL] [Abstract][Full Text] [Related]
11. Valaciclovir versus acyclovir in the treatment of first-episode genital herpes infection. Results of an international, multicenter, double-blind, randomized clinical trial. The Valaciclovir International Herpes Simplex Virus Study Group.
Fife KH; Barbarash RA; Rudolph T; Degregorio B; Roth R
Sex Transm Dis; 1997 Sep; 24(8):481-6. PubMed ID: 9293612
[TBL] [Abstract][Full Text] [Related]
12. Double-blind study comparing 2 dosages of valacyclovir hydrochloride for the treatment of uncomplicated herpes zoster in immunocompromised patients 18 years of age and older.
Arora A; Mendoza N; Brantley J; Yates B; Dix L; Tyring S
J Infect Dis; 2008 May; 197(9):1289-95. PubMed ID: 18422441
[TBL] [Abstract][Full Text] [Related]
13. A randomized, placebo-controlled comparison of oral valacyclovir and acyclovir in immunocompetent patients with recurrent genital herpes infections. The Valaciclovir International Study Group.
Tyring SK; Douglas JM; Corey L; Spruance SL; Esmann J
Arch Dermatol; 1998 Feb; 134(2):185-91. PubMed ID: 9487210
[TBL] [Abstract][Full Text] [Related]
14. The change in zoster-associated pain treated with oral valaciclovir in immunocompetent patients with acute herpes zoster.
Kurokawa I; Murakawa K; Kumano K
Int J Clin Pract; 2007 Jul; 61(7):1223-9. PubMed ID: 17362479
[TBL] [Abstract][Full Text] [Related]
15. Comparison of valaciclovir and acyclovir for the treatment of herpes zoster in immunocompetent patients over 50 years of age: a cost-consequence model.
Grant DM; Mauskopf JA; Bell L; Austin R
Pharmacotherapy; 1997; 17(2):333-41. PubMed ID: 9085325
[TBL] [Abstract][Full Text] [Related]
16. [Erroneous prescriptions of aciclovir and valaciclovir in herpes zoster treatment].
Fica C A; Jadue A C; Donaire R L
Rev Chilena Infectol; 2007 Apr; 24(2):106-10. PubMed ID: 17453067
[TBL] [Abstract][Full Text] [Related]
17. Valaciclovir more effective than acyclovir in reducing pain from shingles.
Infect Control Hosp Epidemiol; 1994 Jan; 15(1):61-2. PubMed ID: 8133011
[No Abstract] [Full Text] [Related]
18. A retrospective study on the clinical outcome of herpes zoster in patients treated with acyclovir or valaciclovir vs. patients not treated with antiviral.
Goh CL; Khoo L
Int J Dermatol; 1998 Jul; 37(7):544-6. PubMed ID: 9679698
[No Abstract] [Full Text] [Related]
19. Comparison between famciclovir and valacyclovir for acute pain in adult Japanese immunocompetent patients with herpes zoster.
Ono F; Yasumoto S; Furumura M; Hamada T; Ishii N; Gyotoku T; Higuchi M; Inokuchi K; Jyo K; Koga H; Komai A; Maruta K; Mashiko T; Mihara T; Miyahara H; Miyasato M; Muto K; Nagase K; Nagata M; Sakihama H; Tanahashi T; Ueda A; Yamakawa K; Ohata C; Dainichi T; Tsuruta D; Hashimoto T
J Dermatol; 2012 Nov; 39(11):902-8. PubMed ID: 22670895
[TBL] [Abstract][Full Text] [Related]
20. Valomaciclovir versus valacyclovir for the treatment of acute herpes zoster in immunocompetent adults: a randomized, double-blind, active-controlled trial.
Tyring SK; Plunkett S; Scribner AR; Broker RE; Herrod JN; Handke LT; Wise JM; Martin PA;
J Med Virol; 2012 Aug; 84(8):1224-32. PubMed ID: 22711350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
